Cigna group EVP sells $3.18 million in company stock

Published 11/03/2025, 22:14
Cigna group EVP sells $3.18 million in company stock

In a recent transaction, Eder Noelle K, the Executive Vice President and Global Chief Information Officer of Cigna Group (NYSE:CI), a prominent healthcare provider with a market capitalization of $86.76 billion and currently trading at $317.87, sold 9,944 shares of the company’s common stock. According to InvestingPro analysis, Cigna appears undervalued with a GREAT financial health score. The shares were sold at a price of $320 each, totaling approximately $3.18 million. This transaction was executed under a Rule 10b5-1 trading plan, which was adopted by Noelle in September 2024.

Following this sale, Noelle retains direct ownership of 13,406 shares. Additionally, Noelle holds 184 shares indirectly through participation in Cigna’s 401(k) plan.

In other recent news, Cigna Corporation has reported a significant shortfall in its fourth-quarter earnings for 2024, with an adjusted earnings per share of $6.64, missing the consensus estimate of $7.82. This shortfall is largely attributed to higher-than-expected costs in its Stop-Loss insurance, driven by increased specialty drug costs and high-acuity surgical procedures. In response to these developments, Piper Sandler has reduced Cigna’s stock price target from $394 to $348 while maintaining an Overweight rating. Similarly, RBC Capital Markets has adjusted its price target for Cigna from $377 to $355, continuing to rate the stock as Outperform.

In another development, The Cigna Group has announced executive changes aimed at improving health outcomes and customer satisfaction. These changes include linking executive compensation to customer satisfaction and publishing an annual Customer Transparency Report starting in 2026. The company is also enhancing its digital tools to streamline care and reduce administrative errors. Additionally, Evernorth Health Services, part of The Cigna Group, is working to ensure patients benefit from lower medication prices negotiated by Express Scripts.

These recent developments highlight both challenges and strategic initiatives undertaken by Cigna to navigate its current financial landscape and improve customer experience.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.